{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:51:11Z","timestamp":1791298271098,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":2358,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemistry & Biology"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1016\/j.chembiol.2006.12.006","type":"journal-article","created":{"date-parts":[[2007,4,18]],"date-time":"2007-04-18T15:46:11Z","timestamp":1176911171000},"page":"153-164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":98,"title":["High-Throughput Screening for Human Lysosomal \u03b2-N-Acetyl Hexosaminidase Inhibitors Acting as Pharmacological Chaperones"],"prefix":"10.1016","volume":"14","author":[{"given":"Michael B.","family":"Tropak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan E.","family":"Blanchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen G.","family":"Withers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don","family":"Mahuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chembiol.2006.12.006_bib1","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.tem.2004.05.003","article-title":"Pharmacological chaperones: potential treatment for conformational diseases","volume":"15","author":"Bernier","year":"2004","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.chembiol.2006.12.006_bib2","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0165-6147(03)00158-5","article-title":"A contradictory treatment for lysosomal storage disorders: inhibitors enhance mutant enzyme activity","volume":"24","author":"Fan","year":"2003","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.chembiol.2006.12.006_bib3","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/j.1600-0854.2004.00232.x","article-title":"Pharmacologic rescue of conformationally-defective proteins: implications for the treatment of human disease","volume":"5","author":"Ulloa-Aguirre","year":"2004","journal-title":"Traffic"},{"key":"10.1016\/j.chembiol.2006.12.006_bib4","doi-asserted-by":"crossref","first-page":"5944","DOI":"10.1002\/anie.200501428","article-title":"Intracellular protein degradation: from a vague idea, through the lysosome and the ubiquitin-proteasome system, and onto human diseases and drug targeting (Nobel Lecture)","volume":"44","author":"Ciechanover","year":"2005","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.chembiol.2006.12.006_bib5","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1096\/fj.04-2375com","article-title":"A synthetic chaperone corrects the trafficking defect and disease phenotype in a protein misfolding disorder","volume":"19","author":"Yam","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.chembiol.2006.12.006_bib6","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1073\/pnas.241629998","article-title":"A peptide that binds and stabilizes p53 core domain: chaperone strategy for rescue of oncogenic mutants","volume":"99","author":"Friedler","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2006.12.006_bib7","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.coph.2004.08.001","article-title":"Pharmacological chaperone action on G-protein-coupled receptors","volume":"4","author":"Bernier","year":"2004","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.chembiol.2006.12.006_bib8","doi-asserted-by":"crossref","first-page":"13478","DOI":"10.1074\/jbc.M308523200","article-title":"Pharmacological enhancement of beta-hexosaminidase activity in fibroblasts from adult Tay-Sachs and Sandhoff patients","volume":"279","author":"Tropak","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.chembiol.2006.12.006_bib9","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/4801","article-title":"Accelerated transport and maturation of lysosomal alpha-galactosidase A in Fabry lymphoblasts by an enzyme inhibitor","volume":"5","author":"Fan","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.chembiol.2006.12.006_bib10","doi-asserted-by":"crossref","first-page":"15428","DOI":"10.1073\/pnas.192582899","article-title":"Chemical chaperones increase the cellular activity of N370S beta-glucosidase: a therapeutic strategy for Gaucher disease","volume":"99","author":"Sawkar","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2006.12.006_bib11","doi-asserted-by":"crossref","first-page":"15912","DOI":"10.1073\/pnas.2536657100","article-title":"Chemical chaperone therapy for brain pathology in G(M1)-gangliosidosis","volume":"100","author":"Matsuda","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.chembiol.2006.12.006_bib12","first-page":"2839","article-title":"The GM2 gangliosidoses","volume":"Volume 2","author":"Gravel","year":"1995"},{"key":"10.1016\/j.chembiol.2006.12.006_bib13","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0022-2836(03)00216-X","article-title":"Crystal structure of human beta-hexosaminidase B: understanding the molecular basis of Sandhoff and Tay-Sachs disease","volume":"327","author":"Mark","year":"2003","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.chembiol.2006.12.006_bib14","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1021\/bi9524575","article-title":"The Direct determination of the substrate specificity of the \u03b1-active site in heterodimeric \u03b2-hexosaminidase A","volume":"35","author":"Hou","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.chembiol.2006.12.006_bib15","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1159\/000112160","article-title":"Biochemical basis of late-onset neurolipidoses","volume":"13","author":"Conzelmann","year":"1991","journal-title":"Dev. Neurosci."},{"key":"10.1016\/j.chembiol.2006.12.006_bib16","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.jmb.2006.04.004","article-title":"Crystallographic structure of human beta-hexosaminidase A: interpretation of Tay-Sachs mutations and loss of G(M2) ganglioside hydrolysis","volume":"359","author":"Lemieux","year":"2006","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.chembiol.2006.12.006_bib17","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0925-4439(91)90044-A","article-title":"The biochemistry of HEXA and HEXB gene mutations causing GM2 gangliosidosis","volume":"1096","author":"Mahuran","year":"1991","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.chembiol.2006.12.006_bib18","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0959-440X(97)80072-3","article-title":"Structural and sequence-based classification of glycoside hydrolases","volume":"7","author":"Henrissat","year":"1997","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.chembiol.2006.12.006_bib19","doi-asserted-by":"crossref","first-page":"6804","DOI":"10.1021\/ja960826u","article-title":"NAG-thiazoline, an N-acetyl-beta-hexosaminidase inhibitor that implicates acetamido participation","volume":"118","author":"Knapp","year":"1996","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.chembiol.2006.12.006_bib20","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0022-2836(03)00311-5","article-title":"The X-ray crystal structure of human beta-hexosaminidase B provides new insights into Sandhoff disease","volume":"328","author":"Maier","year":"2003","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.chembiol.2006.12.006_bib21","doi-asserted-by":"crossref","first-page":"10330","DOI":"10.1074\/jbc.M011067200","article-title":"Crystallographic evidence for substrate-assisted catalysis in a bacterial beta-hexosaminidase","volume":"276","author":"Mark","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.chembiol.2006.12.006_bib22","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nsb0796-638","article-title":"Baterial chitobiase structure provides insight into catalytic mechanism and the basis of Tay-Sachs disease","volume":"3","author":"Tews","year":"1996","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.chembiol.2006.12.006_bib23","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.chembiol.2005.09.007","article-title":"Gaucher disease-associated glucocerebrosidases show mutation-dependent chemical chaperoning profiles","volume":"12","author":"Sawkar","year":"2005","journal-title":"Chem. Biol."},{"key":"10.1016\/j.chembiol.2006.12.006_bib24","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.1046\/j.1432-1327.2000.01457.x","article-title":"In vitro inhibition and intracellular enhancement of lysosomal alpha-galactosidase A activity in Fabry lymphoblasts by 1-deoxygalactonojirimycin and its derivatives","volume":"267","author":"Asano","year":"2000","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.chembiol.2006.12.006_bib25","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1016\/S0960-894X(03)00480-3","article-title":"High throughput screening identifies novel inhibitors of Escherichia coli dihydrofolate reductase that are competitive with dihydrofolate","volume":"13","author":"Zolli-Juran","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.chembiol.2006.12.006_bib26","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.chembiol.2004.08.011","article-title":"High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase","volume":"11","author":"Blanchard","year":"2004","journal-title":"Chem. Biol."},{"key":"10.1016\/j.chembiol.2006.12.006_bib27","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nsmb882","article-title":"The deltaF508 cystic fibrosis mutation impairs domain-domain interactions and arrests post-translational folding of CFTR","volume":"12","author":"Du","year":"2005","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.chembiol.2006.12.006_bib28","first-page":"532","article-title":"Tay-Sachs disease with hexosaminidase A: characterization of the defective enzyme in two patients","volume":"41","author":"Bayleran","year":"1987","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.chembiol.2006.12.006_bib29","unstructured":"Tecan (2001). Shifts in emission and excitation spectra due to pH changes. Application Note SAFIRE."},{"key":"10.1016\/j.chembiol.2006.12.006_bib30","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/0003-2697(80)90198-0","article-title":"A continuous fluorimetric assay for glycosidase activity: human N-acetyl-beta-D-hexosaminidase","volume":"101","author":"Shulman","year":"1980","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.chembiol.2006.12.006_bib31","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A simple statistical parameter for use in evaluation and validation of high throughput screening assays","volume":"4","author":"Zhang","year":"1999","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.chembiol.2006.12.006_bib32","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2174\/1568026023394317","article-title":"Application of high-throughput, molecular-targeted screening to anticancer drug discovery","volume":"2","author":"Shoemaker","year":"2002","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.chembiol.2006.12.006_bib33","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1177\/106002809302700616","article-title":"Aldose reductase inhibitors: an update","volume":"27","author":"Tsai","year":"1993","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.chembiol.2006.12.006_bib34","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/j.1552-4604.1986.tb02951.x","article-title":"A decade of developments in diuretic drug therapy","volume":"26","author":"Hutcheon","year":"1986","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.chembiol.2006.12.006_bib35","doi-asserted-by":"crossref","first-page":"25313","DOI":"10.1074\/jbc.M413819200","article-title":"O-GlcNAcase uses substrate-assisted catalysis: kinetic analysis and development of highly selective mechanism-inspired inhibitors","volume":"280","author":"Macauley","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.chembiol.2006.12.006_bib36","first-page":"257","article-title":"Bis-naphthalimides: a new class of antitumor agents","volume":"8","author":"Brana","year":"1993","journal-title":"Anticancer Drug Des."},{"key":"10.1016\/j.chembiol.2006.12.006_bib37","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1091\/mbc.e05-06-0579","article-title":"Rescue of vasopressin V2 receptor mutants by chemical chaperones: specificity and mechanism","volume":"17","author":"Robben","year":"2006","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.chembiol.2006.12.006_bib38","doi-asserted-by":"crossref","first-page":"6195","DOI":"10.4049\/jimmunol.174.10.6195","article-title":"Mechanisms of dimethyl sulfoxide augmentation of IL-1 beta production","volume":"174","author":"Xing","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.chembiol.2006.12.006_bib39","doi-asserted-by":"crossref","first-page":"4937","DOI":"10.1016\/S0021-9258(19)85585-0","article-title":"Biosynthesis of lysosomal enzymes in fibroblasts: synthesis as precursors of higher molecular weight","volume":"255","author":"Hasilik","year":"1980","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.chembiol.2006.12.006_bib40","doi-asserted-by":"crossref","first-page":"4946","DOI":"10.1016\/S0021-9258(19)85586-2","article-title":"Biosynthesis of lysosomal enzymes in fibroblasts: phosphorylation of mannose residues","volume":"255","author":"Hasilik","year":"1980","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.chembiol.2006.12.006_bib41","doi-asserted-by":"crossref","first-page":"11070","DOI":"10.1016\/S0021-9258(18)90623-X","article-title":"Faulty association of \u03b1- and \u03b2-subunits in some forms of \u03b2-hexosaminidase A deficiency","volume":"259","author":"d'Azzo","year":"1984","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.chembiol.2006.12.006_bib42","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0014-5793(98)01578-6","article-title":"Application of magnetic chromatography to the isolation of lysosomes from fibroblasts of patients with lysosomal storage disorders","volume":"441","author":"Diettrich","year":"1998","journal-title":"FEBS Lett."},{"key":"10.1016\/j.chembiol.2006.12.006_bib43","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0006-2944(70)90056-6","article-title":"G M1-gangliosidosis (type II): studies on a fibroblast cell strain","volume":"4","author":"Callahan","year":"1970","journal-title":"Biochem. Med."},{"key":"10.1016\/j.chembiol.2006.12.006_bib44","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1367-5931(00)00135-6","article-title":"Glycosidase mechanisms","volume":"4","author":"Rye","year":"2000","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.chembiol.2006.12.006_bib45","doi-asserted-by":"crossref","first-page":"6273","DOI":"10.1021\/jo049355h","article-title":"Synthesis and high-throughput screening of N-acetyl-beta-hexosaminidase inhibitor libraries targeting osteoarthritis","volume":"69","author":"Liu","year":"2004","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.chembiol.2006.12.006_bib46","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2174\/1568011013354624","article-title":"Naphthalimides as anti-cancer agents: synthesis and biological activity","volume":"1","author":"Brana","year":"2001","journal-title":"Curr. Med. Chem. Anti-Canc. Agents"},{"key":"10.1016\/j.chembiol.2006.12.006_bib47","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/cbic.200500321","article-title":"Novel five-membered iminocyclitol derivatives as selective and potent glycosidase inhibitors: new structures for antivirals and osteoarthritis","volume":"7","author":"Liang","year":"2006","journal-title":"ChemBioChem"},{"key":"10.1016\/j.chembiol.2006.12.006_bib48","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/S0959-8049(02)00776-1","article-title":"An EORTC-ECSG phase I study of LU 79553 administered every 21 or 42 days in patients with solid tumours","volume":"39","author":"Awada","year":"2003","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.chembiol.2006.12.006_bib49","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1200\/JCO.2001.19.3.857","article-title":"Phase I and pharmacokinetic study of LU79553, a DNA intercalating bisnaphthalimide, in patients with solid malignancies","volume":"19","author":"Villalona-Calero","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.chembiol.2006.12.006_bib50","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1021\/jm030480f","article-title":"Selective optimization of side activities: another way for drug discovery","volume":"47","author":"Wermuth","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.chembiol.2006.12.006_bib51","first-page":"497","article-title":"\u03b2-hexosaminidase isozymes from cells co-transfected with \u03b1 and \u03b2 cDNA constructs: analysis of \u03b1 subunit missense mutation associated with the adult form of Tay-Sachs disease","volume":"53","author":"Brown","year":"1993","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.chembiol.2006.12.006_bib52","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/07328308908048567","article-title":"Synthesis and inhibitory properties of 2-acetamido-2-deoxynojirimycin (2-acetamido-5-amino-2,5-dideoxy-D-glucopyranose, 1) and 2-acetamido-1,2-dideoxynojirimycin (2-acetamido-1,5-imino-1,2,5-trideoxy-D-glucitol, 2)","volume":"8","author":"Kappes","year":"1989","journal-title":"J. Carbohydr. Chem."},{"key":"10.1016\/j.chembiol.2006.12.006_bib53","series-title":"Enzymes of Lipid Metabolism II","first-page":"779","article-title":"Molecular heterogeneity in O-variant GM2 gangliosidosis","author":"O'Dowd","year":"1986"},{"key":"10.1016\/j.chembiol.2006.12.006_bib54","doi-asserted-by":"crossref","first-page":"20799","DOI":"10.1016\/S0021-9258(17)45286-0","article-title":"Translation initiation in the HEXB gene encoding the \u03b2-subunit of human \u03b2-hexosaminidase","volume":"265","author":"Neote","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.chembiol.2006.12.006_bib55","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0378-1119(95)00848-9","article-title":"N-acetylglucosaminidase (chitobiase) from Serratia marcescens: gene sequence, and protein production and purification in Escherichia coli","volume":"170","author":"Tews","year":"1996","journal-title":"Gene"},{"key":"10.1016\/j.chembiol.2006.12.006_bib56","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0022-3565(24)39308-5","article-title":"Evaluation of\u00a0a minimal experimental design for determination of enzyme kinetic parameters and inhibition mechanism","volume":"293","author":"Kakkar","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.chembiol.2006.12.006_bib57","doi-asserted-by":"crossref","first-page":"21386","DOI":"10.1074\/jbc.273.33.21386","article-title":"A Pro504Ser substitution in the \u03b2-subunit of \u03b2-hexosaminidase A inhibits \u03b1-subunit hydrolysis of GM2 ganglioside, resulting in chronic Sandhoff disease","volume":"273","author":"Hou","year":"1998","journal-title":"J. Biol. Chem."}],"container-title":["Chemistry & Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074552106004698?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074552106004698?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T07:08:19Z","timestamp":1761030499000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1074552106004698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S1074552106004698"],"URL":"https:\/\/doi.org\/10.1016\/j.chembiol.2006.12.006","relation":{},"ISSN":["1074-5521"],"issn-type":[{"value":"1074-5521","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-Throughput Screening for Human Lysosomal \u03b2-N-Acetyl Hexosaminidase Inhibitors Acting as Pharmacological Chaperones","name":"articletitle","label":"Article Title"},{"value":"Chemistry & Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chembiol.2006.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}